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Complications of tattoos are a growing concern,
especially because more than 21% of American
adults now have at least 1 tattoo.1 Overall, few tattoo
reactions have been described in HIV patients, and
all of the cases reported occurred after antiretroviral
therapy (ART) initiation, attributed either to immune
reconstitution syndrome (IRS) or leishmaniasis
infiltration.2-7 To our knowledge, there are no
reported cases of tattoo reaction in HIV patients
not on ART. We describe an HIV patient with an
allergic tattoo reaction at baseline that dramatically
worsened after ART initiation, which was further
complicated by a severe id reaction.CASE REPORT
A 40-year-old woman with a 7-year history of HIV
infection underwent tattooing of 2 red ink ‘‘bleeding
hearts’’ on her chest in December 2012. In the days
following, erythema and swelling developed at the
tattoo sites. She had received multiple prior tattoos
without complications, including one on the lower
back with red ink. The tattoo eruptions on the chest
remained stable over the next 6 months, isolated to
the areas of red ink, and did not respond to
treatments from urgent care including topical
silver sulfadiazine ointment, empiric oral itracona-
zole, and topical betamethasone dipropionate 0.05%
ointment.
In June 2013, the patient presented to the
Infectious Disease Clinic for a consultation regarding
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rora, CO 80045. E-mail: mariah.brown@ucdenver.edu.increasing viral load count and low CD4 cell count.
Their examination noted erythema and swelling
isolated to the tattoos on her chest. At that visit, her
CD4 count was 384 cells per microliter and viral load
was 5,940 copies per milliliter. The patient was
started on elvitegravir-cobicistat-emtricitabine-
tenofovir 150-150-200-300 mg (Stribild; Gilead
Sciences, Foster City, CA) tablet once daily, and
was referred to dermatology.
The patient was seen in the Dermatology Clinic in
August 2013. Her tattoo reactions had worsened after
starting ART and were not improving despite
application of topical betamethasone dipropionate
0.05% ointment twice daily for more than 4 months.
On examination, eroded plaques weeping clear-
yellow fluid were isolated to the red portions of
her chest tattoos. An allergic reaction to red ink was
suspected, and intralesional triamcinolone was
injected into both tattoos (a total of 2 mL triamcin-
olone solution, 10 mg/mL, across both tattoos). Two
weeks later, the patient returned with a new
generalized pruritic rash and no improvement in
her localized tattoo reactions. On examination, she
was found to have erythematous papules on her
face, trunk, and extremities (Fig 1, B and C ). Her
chest tattoos remained eroded with clear-yellowJAAD Case Reports 2015;1:395-8.
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Fig 1. Allergic reaction to red tattoo ink and autoeczematization. A, Edematous, weeping
plaques isolated to the red portions of recently acquired ‘‘bleeding heart’’ tattoos on the chest.
B and C, Erythematous, edematous papules on the face and ventral forearms. D, New
erythematous, crusted plaque within the red portion of a tattoo acquired 17 years prior at a
different tattoo parlor.
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viral load was undetectable, indicating an excellent
initial response to ART. She was started on an oral
prednisone taper (60 mg by mouth for 4 days,
tapered by 10 mg every 4 days, for a total course of
24 days) for presumed allergic tattoo reaction with
autoeczematization (id reaction).
The tattoo reactions and generalized papular
eruption resolved completely on oral prednisone,
but recurred 3 days after the taper was completed in
October 2013. In addition, at the time of steroid
discontinuation, the patient then had a new allergic
reaction within the red portion of her lower back
tattoo, whereas the blue, green, and black portions
were spared (Fig 1, D). This tattoo had been present
for 17 years and had been completed at a different
tattoo parlor than her more recent tattoos. At this
time, 2 biopsies were performed from the left chest
tattoo and sent for histopathology and tissue culture.
Histopathology findings showed dermal red tattoo
pigment deposition and an extensive associated
inflammatory infiltrate consisting primarily of lym-
phocytes and occasional eosinophils with varying
degrees of lichenoid and spongiotic tissue reaction.
Bacterial, fungal, and mycobacterial tissue cultures
were negative. A second prednisone taper wascommenced, with prednisone 30 mg daily for
2 weeks, followed by 20 mg daily for 8 weeks, while
staged surgical excision of the 3 tattoos was
completed over 8 weeks beginning in November
2013. Histopathology results from each tattoo exci-
sion confirmed the same pathologic findings as in the
previous left chest tattoo biopsy (Fig 2, A and B).
Tissue cultures from each specimen (bacterial,
fungal, and mycobacterial) were also negative.
Upon discontinuation of the prednisone after tattoo
excision, the generalized papular eruption of her id
reaction had not recurred at 2-year follow-up.
DISCUSSION
Red ink reactions are the most frequently
described among allergic tattoo reactions. In the
past, the proposed culprit in red ink was cinnabar
(mercury sulfide), but reactions to red ink continued
even as mercury-free inks replaced older mercury-
containing inks beginning in the 1970s.8,9 Modern
red tattoo inks are primarily composed of organic
azo pigments.10,11 Efforts to identify the specific
culprit allergen within these new red inks have
been disappointing and suggest that either
metabolism or haptenization with host proteins
within the dermis is likely required for an allergic
Fig 2. Histopathology from surgical excision of tattoos.
A and B, Dermal red tattoo pigment deposition and an
extensive inflammatory infiltrate consisting primarily of
lymphocytes and occasional eosinophils with varying
degrees of lichenoid and spongiotic tissue reaction.
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help explain why patch and prick testing is generally
negative in patients with tattoo ink reactions, even
when the same ink that was used for the tattoo is
applied to the skin. Although intradermal testingmay
better replicate the reaction, it is largely discouraged
given the risk of permanent tattooing and further
irreversible allergic reaction.10,12 In our patient’s
case, efforts to contact the tattoo parlor regarding
the red ink type were not successful, and patch
testing was not undertaken given the aforemen-
tioned ineffectiveness.
Selective reactions toward recently acquired
versus old tattoos of the same color ink have been
described previously.13 Kuo et al13 described an
otherwise healthy woman who had an allergic
reaction toward the red ink in a new tattoo, whereas
2 tattoos with red ink from 20 years prior remained
uninvolved. All tattoos were completed at the same
tattoo shop, although they were unable to confirm
the tattoo ink types. The authors suggest that the
patient’s immune system was sensitized by the old
tattoos, leading to a greater response with the new
tattoo. It also seems possible that the tattoo inks may
have had different components, and thus were not
cross-reactive. In contrast to this prior case, ourpatient initially reacted only to her new tattoos, but
after ART initiation she also developed a reaction to
her older tattoo from 17 years prior. Her reaction to
this older tattoo was likely secondary to sensitization
from the new tattoos, which probably had a shared
component in the red ink, and to a promoted
immune response in the setting of ART. Another
case of delayed tattoo reaction has been described in
a T-cell lymphoma patient who reacted to tattoos
obtained 20 years prior shortly after his autologous
bone marrow transplant14; presumably, this reaction
was also caused by a promoted immune response as
in our patient.
Although our patient’s pruritic papular eruption
was not biopsied, we feel that the appearance of the
eruption in the setting of chronic allergic tattoo
reaction and enhanced immune reactivity when
starting ART makes an id reaction highly likely.
Furthermore, the eruption improved simultaneously
with the tattoo reactionswhile on oral corticosteroids
and completely resolved with tattoo excision.
Another possible etiology for this papular eruption
in an HIV patient includes eosinophilic folliculitis,
but this generally presents at CD4 cell counts less
than 200 and would not rapidly resolve with oral
corticosteroids.15
To date, reactions to tattoos in HIV patients have
only been reported after ART initiation, and each
presented as a granulomatous reaction that
self-resolved within 3 months without significant
intervention.2-4 These cases were considered
cutaneous manifestations of IRS, which is a
pathologic inflammatory response to a preexisting
antigen in HIV patients after starting ART, most
commonly a pathogen such as a virus or bacteria.
When ART is initiated, HIV viral replication is
suppressed and CD41 cells increase in number,
restoring pathogen-specific immunity that is
generally protective, although in some patients an
immunopathologic response may result.15 Of the
aforementioned IRS cases, only one case was a
reaction to tattoo ink (black); the other 2 reactions
were directed toward traumatic tattoos (a traumatic
tattoo generally refers to traumatic implantation
of foreign material into the skin). In all 3 of these
cases, the reaction involved the entirety of the tattoos.
Another tattoo reaction documented in HIV patients
is cutaneous tattoo infiltration by leishmaniasis.
Initiation of ART preceded the cutaneous symptoms
in each of these cases as well,5-7 thus representing
another possible manifestation of IRS in HIV.
Our case is unique, as this HIV patient had an
allergic reaction to red tattoo pigment before ART,
with an amplified, progressive reaction complicated
by autoeczematization after ART was initiated.
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not at a level considered consistent with IRS. Also,
unlike the aforementioned HIV patients, her reaction
lasted 11 months without resolution and had a
lichenoid and spongiotic pattern on histopathology
rather than a granulomatous pattern. To our knowl-
edge, autoeczematization in the setting of allergic
tattoo reaction has not been described previously in
any population.
All people are at risk of allergic tattoo reactions. As
this case demonstrates, HIV patients may be at
increased risk of severe tattoo reactions, particularly
in the context of ART initiation. Given the increasing
popularity of tattoos, patients should be made aware
of the inflammatory risks that tattoo inks pose and
that HIV patients may have some unique risk factors
for tattoo reactions.
The authors are indebted to Lisa Litzenberger,
University of Colorado Department of Pathology, for her
assistance in preparing the figures for this manuscript.REFERENCES
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